What is NDC 0143-9269?

0143-9269 is the product NDC for Clindamycin in 5 percent Dextrose, Clindamycin 18 mg/mL injection, solution, listed with the FDA by Hikma Pharmaceuticals USA Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.

Hikma Pharmaceuticals USA Inc., NDC labeler code 0143. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Clindamycin in 5 percent Dextrose?

7 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Clindamycin in 5 percent Dextrose NDC 0143-9269

NDC codes

FDA NDC Directory

Product NDC (as listed)0143-9269Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00143-9269Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0143-9269-01	0014392690100143926901	1 VIAL in 1 CARTON (0143-9269-01) / 50 mL in 1 VIALMarketed from Jun 12, 2024

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Clindamycin in 5 percent Dextrose
Generic name (nonproprietary): clindamycin in 5 percent dextrose
Active ingredients: Clindamycin — 18 mg/mL
Dosage form: Injection, Solution
Route: Intravenous
Labeler: Hikma Pharmaceuticals USA Inc.NDC labeler code 0143
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 214401
Marketing start: Jun 12, 2024
Listing expires: Dec 31, 2026
Other FDA classes: Decreased Sebaceous Gland Activity (Physiologic effect)Lincosamides (Chemical structure)Neuromuscular Blockade (Physiologic effect)
Identifiers: Product ID 0143-9269_0dbb7c39-4e79-4a6a-9f25-d4920b2e6562SPL ID 0dbb7c39-4e79-4a6a-9f25-d4920b2e6562SPL set ID 8b452032-abed-495b-b518-15623e9850a3RxCUI 309335, 309336, 309339UNII 3U02EL437C
Pharmacologic class: Lincosamide Antibacterial

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N400143926901 followed by a unit qualifier and the quantity

Package 00143-9269-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jul 18, 2024. This label includes a boxed warning.

Indications (excerpt from the label)

INDICATIONS AND USAGE Clindamycin in 5% dextrose injection is indicated in the treatment of serious infections caused by susceptible anaerobic bacteria. Clindamycin in 5% dextrose injection is also indicated in the treatment of serious infections due to susceptible strains of streptococci, pneumococci, and staphylococci. Its use should be reserved for penicillin-allergic patients or other patients for whom, in the judgment of the physician, a penicillin is inappropriate. Because of the risk of antibiotic-associated pseudomembranous colitis, as described in the BOXED WARNING , before selecting clindamycin the physician should consider the nature of the infection and the suitability of less to…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 0143-9269

What is NDC 0143-9269?: 0143-9269 is the product NDC for Clindamycin in 5 percent Dextrose, Clindamycin 18 mg/mL injection, solution, listed with the FDA by Hikma Pharmaceuticals USA Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Clindamycin in 5 percent Dextrose.
What is the active ingredient?: Clindamycin.
Who is the labeler?: Hikma Pharmaceuticals USA Inc., NDC labeler code 0143. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Clindamycin in 5 percent Dextrose?: 7 other product NDCs are listed under this name. See all Clindamycin in 5 percent Dextrose NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Clindamycin in 5 percent Dextrose NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Clindamycin in 5 percent Dextroseclindamycin in percent dextrose	Clindamycin 6 mg/mL	Injection, SolutionIntravenous	Hikma Pharmaceuticals USA Inc.	0143-9267	00143-9267-01
Clindamycin in 5 percent Dextrose	Clindamycin 12 mg/mL	Injection, SolutionIntravenous	Hikma Pharmaceuticals USA Inc.	0143-9268	00143-9268-01
Clindamycin in 5 Percent Dextrose	Clindamycin 12 mg/mL	Injection, SolutionIntravenous	Civica, Inc.	72572-074	72572-0074-24
Clindamycin in 5 Percent Dextrose	Clindamycin 18 mg/mL	Injection, SolutionIntravenous	Civica, Inc.	72572-076	72572-0076-24
Clindamycin in 5 Percent Dextrose	Clindamycin 6 mg/mL	Injection, SolutionIntravenous	Sandoz Inc	0781-3288	00781-3288-09
Clindamycin in 5 Percent Dextrose	Clindamycin 12 mg/mL	Injection, SolutionIntravenous	Sandoz Inc	0781-3289	00781-3289-09
Clindamycin in 5 Percent Dextrose	Clindamycin 18 mg/mL	Injection, SolutionIntravenous	Sandoz Inc	0781-3290	00781-3290-09

Other NDCs under ANDA 214401

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 214401
Product	Strength	Form · route	Labeler	Product NDC
Clindamycin in 5 percent Dextroseclindamycin in percent dextrose	Clindamycin 6 mg/mL	Injection, SolutionIntravenous	Hikma Pharmaceuticals USA Inc.	0143-9267
Clindamycin in 5 percent Dextrose	Clindamycin 12 mg/mL	Injection, SolutionIntravenous	Hikma Pharmaceuticals USA Inc.	0143-9268